AstraZeneca shares slip as Q4 profits miss forecasts
8th Feb 2024 07:58
(Sharecast News) - Biopharma titan AstraZeneca delivered a 6% increase in sales in 2023 despite a $3.7bn decline in Covid-19 medicines revenues, as it guided to a strong pick-up in growth this year - though profits came in slightly under analysts' forecasts.
Read moreLondon close: Stocks finish lower as wage growth eases
16th Jan 2024 16:17
(Sharecast News) - London's stock markets finished in the red on Tuesday, as investors assessed the latest UK jobs data.
Read moreUBS downgrades AstraZeneca to 'sell'
16th Jan 2024 08:15
(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.
Read moreLondon close: Stocks fall amid rising geopolitical concerns
3rd Jan 2024 17:48
(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.
Read moreJefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'
3rd Jan 2024 11:07
(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.
Read moreLondon close: Stocks maintain gains amid post-Christmas rally
27th Dec 2023 14:25
(Sharecast News) - London's stock markets closed in positive territory on Wednesday, buoyed by a global surge in stock prices as the S&P 500 neared an all-time high on Wall Street.
Read moreLondon midday: Stocks ride global wave of post-Christmas optimism
27th Dec 2023 11:20
(Sharecast News) - London's equity markets were still above the waterline at lunchtime on Wednesday, following a late Santa rally on Wall Street overnight.
Read moreLondon open: FTSE takes cues from Wall Street 'Santa rally'
27th Dec 2023 08:26
(Sharecast News) - London's stocks returned from the Christmas break in the green on Wednesday, boosted by a late Santa rally on Wall Street overnight.
Read moreAstraZeneca to buy Gracell Technologies for $1.2bn
27th Dec 2023 07:02
(Sharecast News) - AstraZeneca on Wednesday said it was buying Gracell Biotechnologies, a global clinical-stage biopharmaceutical company developing cell therapies for the treatment of cancer and autoimmune diseases, for $1.2bn.
Read moreAstraZeneca gets FDA green light for nerve disease treatment
22nd Dec 2023 07:17
(Sharecast News) - The US Food and Drug Administration has approved the Wainua nerve disease treatment jointly developed by AstraZeneca and Ionis Pharmaceuticals.
Read moreLondon close: Stocks slip as investors digest US inflation
12th Dec 2023 16:00
(Sharecast News) - London's markets finished in the red on Tuesday, as investors digested a slight decrease in consumer inflation in the US, while the UK's unemployment figures remained stable.
Read moreLondon midday: FTSE still firmer ahead of US inflation print
12th Dec 2023 12:07
(Sharecast News) - London's markets remained relatively stable by midday on Tuesday, with the top-flight index still in the green after fresh jobs data showed a slowdown in wage growth.
Read moreAstraZeneca to buy US vaccine maker Icosavax for up to $1.1bn
12th Dec 2023 07:16
(Sharecast News) - AstraZeneca said on Tuesday that it has agreed to buy Icosavax - a US-based clinical-stage biopharmaceutical company - for up to $1.1bn.
Read moreAstraZeneca calls off two phase III trials into hyperkalaemia treatment
1st Dec 2023 08:01
(Sharecast News) - Drugmaker AstraZeneca has called off two phase III trials on its hyperkalaemia treatment after a series of logistical challenges.
Read moreLondon close: Stocks start week in subdued state
27th Nov 2023 16:12
(Sharecast News) - London's financial markets saw a somewhat subdued performance on Monday, as concerns regarding the Chinese economy cast a shadow over investor sentiment.
Read more